“A substantial reduction of uncertainties in clinical brachytherapy should result in improved outcome
in terms of increased local control and reduced side effects. Types of uncertainties have to be
identified, grouped, and quantified.”
•
Comprehensive literature review of uncertainty components in Brachytherapy for different clinical sites, and
their relative importance to the combined overall dosimetric uncertainty.
•
Examples for gyn, prostate, breast BT that can be used as templates for future dose and uncertainty reporting.